Skip to Content

Notice

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study: Disease Information in Branded Promotional Material

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Experimental Study: Disease Information in Branded Promotional Material” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-5156, Daniel.Gittleson@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

On June 20, 2012, the Agency submitted a proposed collection of information entitled “Experimental Study: Disease Information in Branded Promotional Material” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0724. The approval expires on November 30, 2015. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.

Dated: December 6, 2012.

Leslie Kux,

Assistant Commissioner for Policy.

[FR Doc. 2012-29931 Filed 12-11-12; 8:45 am]

BILLING CODE 4160-01-P